Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Raid Ghassan Alany

Raid Ghassan Alany

Head of School and Professor
Kingston University London, UK
Honorary Professor
The University of Auckland, New Zealand

Biography

Professor Raid Alany has over 25 years of international experience in health sciences education, pharmaceutics and drug delivery research. His academic journey spans three continents; namely, Asia, Oceania and Europe. He received his PhD in ocular drug delivery from the University of Otago, Dunedin New Zealand in 2001; was appointed as a Lecturer at the School of Pharmacy, The University of Auckland, New Zealand, in 2001 where he was responsible for establishing the first pharmaceutics curriculum there. He was promoted to a Senior Lecturer in 2004, appointed as Head of Pharmaceutics in 2007, promoted to Senior Lecturer above the bar in February 2009; appointed as Honorary Professor in 2011. He joined Kingston University London as Professor (Chair) of Pharmaceutics in January 2011 and was appointed as Research Director for the School of Pharmacy and Chemistry in December 2013. He was appointed as the Inaugural Head of School of Life Sciences, Pharmacy and Chemistry on 1st of June 2015. This ‘’super’’ school is the largest in Kingston University London comprising four departments, well over 2000 students, over 100 academic staff with an operational budget of £5.7M (August 2015 to July 2016). Professor Alany has been registered as a Pharmacist in New Zealand since July 1999; he became a Fellow of the New Zealand College of Pharmacists in 2003. He currently leads a research team comprising a CARA Visiting Fellow, Leverhulme Visiting Fellow, six PhD students and a Sparks Research Fellow working on a range of drug delivery projects; he has supervised to completion 20 Masters by Research and PhD students. Raid is an author on over 200 scientific research publications (papers and abstracts), a book and seven book chapters; he has attracted over $NZ 2M (£GBP 1M) in contestable research and enterprise funding. Professor Alany acts as Editor-in-Chief for Pharmaceutical Development and Technology (IF 1.566); Section Editor for Clinical and Experimental Ophthalmology the official journal of the Royal Australian and New Zealand College of Ophthalmologists (IF 2.546); Chief Patron, Drug Development and Therapeutics, a publication of Organization of Pharmaceutical Unity with BioAllied Sciences (OPUBS). He serves on the Editorial Board of the following journals: Current Medical Research and Opinion (IF 2.643); BioMed Research International (IF 2.134); Journal of Drug Delivery Science and Technology (IF 0.620); Current Drug Delivery (IF 1.446); Pharmaceutics MDPI; Journal of Pharmaceutical Policy and Practice and Drug Delivery Letters. He is the Immediate Past President of the New Zealand Chapter of the Controlled Release Society (NZCRS); member of the Scientific Steering Group of the New Zealand National Eye Centre (NZ-NEC); past member of the International Pharmaceutical Federation (FIP) and Australasian Pharmaceutical Scientists Association (APSA). Raid won several awards such as Microscopy New Zealand Young Scientists Award in 1999; The University of Auckland's Vice Chancellor's Early Career Research Excellence Award in 2003; Controlled Release Society Veterinary Programme co-chair/ chair Distinguished Service Awards in 2008/2009 and the Spark Ideas Challenge, Uniservices Prize and Chiasma Prize in 2011. He consults for human and animal health pharmaceutical companies in New Zealand and Australia and is an inventor on international patents; he receives regular invitations to present at international meetings and provide expert opinion to drug registration and regulatory bodies.

Research Interest

Ophthalmic Drug Delivery, Lipid and Surfactant Based Drug Delivery Systems, Delivery of Antisense Oligonucleotides and siRNA, In Situ Gelling Systems, Veterinary Pharmaceuticals.